# Bloomage BioTechnology

> Bloomage BioTechnology is a VC fund backing Biotechnology and Robotics. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 4
- Last investment: Mar 2026
- Lead investor: 75%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/bloomage-biotechnology-corporation-limited
- X (Twitter): https://twitter.com/bloomagebiotech
- Website: http://www.bloomagebio-tech.com/e/index.php
- Facebook: https://www.facebook.com/bloomagebiotech

Bloomage BioTechnology is a VC fund in Beijing focused on Biotechnology and Robotics. Bloomage BioTechnology (the “Company”, collectively referred to as the “Group” together with its subsidiaries), founded on 3rd April, 2006 in the Cayman Islands, is an International Group dedicated to develop in the field of biomedicine. Its core subsidiary is a manufacturer and distributor of sodium hyaluronic acid (referred to as “HA”) andfocuses mainly on the development, manufacture and sale of various HA raw materials and end products. The Group has been listed on the Main Board of the Stock Exchange of Hong Kong with the stock code 00963.

## Contacts

5 contacts available for Bloomage BioTechnology. Shizune tracks 2 team members at Bloomage BioTechnology. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/bloomage-biotechnology-corporation-limited?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 50% |
| Robotics | 1 | 25% |
| Biopharma | 1 | 25% |
| Manufacturing | 1 | 25% |
| Medical Device | 1 | 25% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 50% |
| Seed | 1 | 25% |
| Post-IPO Equity | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 3 | 75% |
| United States | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jin Xuekun | Chief Executive Officer & Executive Director | 1 | — |
| Liang Shuang | Head of Investment | 2 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Synthetic Era | Synthera was established through the transformation of research achievements from Tsinghua University and has been continuously delivering technological advancements.Aligning with China's Carbon Peak and Neutrality goals, Synthera focuses on high-value enzyme preparations through premium, specialized, and customized product strategies.Leveraging our innovative core technologies, industrial-scale capabilities, and efficient operations, we deliver competitive biocatalytic solutions that enhance quality of life. |  | Seed | Mar 27, 2026 |  |
| Sirnaomics | Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology. | $17.7M | Post-IPO Equity | Sep 07, 2025 |  |
| AI² Robotics | AI² Robotics is an embodied intelligent robot company that offers research and development of general intelligent embodied terminals. | $14M | Series A | Sep 01, 2025 |  |
| Shanhai Innovation | Shine+ is a diversified high-tech biological development company. | $29.9M | Series A | Jun 24, 2022 |  |

4 of 4 investments shown.

## Co-investors
- [Cowin Capital](https://shizune.co/investors/profile/cowin-capital) — VC Fund, 1 deal together
- [Dunhong Capital Management](https://shizune.co/investors/profile/dunhong-capital-management) — VC Fund, 1 deal together
- [Guotou Chuangying](https://shizune.co/investors/profile/guotou-chuangying) — VC Fund, 1 deal together
- [Hongtai Fund](https://shizune.co/investors/profile/hongtai-fund) — VC Fund, 1 deal together
- Hongxin Ziben — VC Fund, 1 deal together
- [Oriental Fortune Capital](https://shizune.co/investors/profile/oriental-fortune-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Bloomage BioTechnology invest in?

Bloomage BioTechnology invests primarily in Biotechnology, Robotics and Biopharma startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Bloomage BioTechnology?

Public channels for Bloomage BioTechnology include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Bloomage BioTechnology?

The team at Bloomage BioTechnology includes Jin Xuekun (Chief Executive Officer & Executive Director) and Liang Shuang (Head of Investment). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co